Renal Function Clinical Trials

4 recruiting

Renal Function Trials at a Glance

9 actively recruiting trials for renal function are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Alexandroupoli, Atlanta, and Auburn. Lead sponsors running renal function studies include Azienda Usl di Bologna, Central Hospital, Nancy, France, and Auburn University.

Browse renal function trials by phase

Treatments under study

About Renal Function Clinical Trials

Looking for clinical trials for Renal Function? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Renal Function trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Renal Function clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

The Cold Ischemia Robot-assisted Partial Nephrectomy

Renal Cell CarcinomaRenal Function Abnormal
Sun Yat-sen University310 enrolled1 locationNCT07326280
Recruiting

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population

Kidney TransplantKidney DiseaseTransplant Recipient+1 more
Devyser Inc.400 enrolled6 locationsNCT07006831
Recruiting
Not Applicable

Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients

Diabetic Macular Edema (DME)Renal Function Disorder
University Hospital, Alexandroupolis60 enrolled2 locationsNCT06929507
Recruiting

Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease

Chronic Kidney DiseaseType 2 Diabetes MellitusRenal Function
Second Affiliated Hospital of Soochow University300 enrolled1 locationNCT06838416
Recruiting

Renal Nerve Denervation(RDN) and Renal Function

Effects of RDN on Renal Function
Zhengrong Huang50 enrolled1 locationNCT05612906
Recruiting
Not Applicable

Urinary Creatinine Excretion Time in the Neonatal Period

Renal Function
Central Hospital, Nancy, France40 enrolled1 locationNCT05813730
Recruiting
Phase 4

Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock

Septic ShockRenal Function Replacement
Azienda Usl di Bologna264 enrolled1 locationNCT06471231
Recruiting
Not Applicable

The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function

Blood PressureCardiovascular Risk FactorRenal Function+1 more
Auburn University60 enrolled1 locationNCT04334135
Recruiting
Not Applicable

Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients

Peritoneal Dialysis ComplicationSodium-glucose Co-transporter-2 InhibitorsRenal Function Aggravated
Sichuan Academy of Medical Sciences70 enrolled1 locationNCT06398977